Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-09 Sale | 2024-09-09 9:20 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 2,490 | $11.52 | $28,685 | 74,595 (Direct) | View |
| 2024-09-04 Sale | 2024-09-05 9:30 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 514 | $9.5093 | $4,888 | 70,335 (Direct) | View |
| 2024-04-11 Sale | 2024-04-12 4:05 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 54 | $6.74 | $364 | 70,849 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 4:05 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 3,818 | $8.5313 | $32,573 | 135,903 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 4:10 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 853 | $9.0684 | $7,735 | 49,721 (Direct) | View |
| 2023-09-05 Sale | 2023-09-05 8:15 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 457 | $14.71 | $6,723 | 50,574 (Direct) | View |
| 2023-05-10 Sale | 2023-05-12 4:14 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 455 | $16.59 | $7,548 | 51,031 (Direct) | View |
| 2023-04-11 Sale | 2023-04-13 4:07 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 47 | $21.49 | $1,010 | 51,486 (Direct) | View |
| 2023-02-01 Sale | 2023-02-02 7:02 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 1,588 | $21.75 | $34,542 | 112,783 (Direct) | View |
| 2023-01-24 Sale | 2023-01-26 4:05 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 852 | $21.9 | $18,663 | 32,871 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-05 Option Award | 2024-09-09 9:20 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 6,750 | $0 | 74,595 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-30 | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 90,000 | $0 | 135,903 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 7:02 pm | N/A 2033-01-30 | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 81,500 | $0 | 112,783 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-01 6:20 pm | N/A 2032-08-31 | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 62,840 | $0 | 91,563 (Direct) | View |
Ownership | 2022-09-01 6:19 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 0 | $0 | 197,473 (Direct) | View |